Clincosm LogoSign in Get a demo

Patterns of Urinary Bladder Cancer in Darfur, Suda

Sponsor
National Center for Gastroentestinal and Liver Disease (Other)
Overall Status
Completed
CT.gov ID
NCT06156787
Collaborator
(none)
105
Enrollment
1
Location
17.2
Actual Duration (Months)
6.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Background: Bladder cancer (BC) exhibits extreme heterogeneity regarding clinical outcome, etiology, histology, and geographic distribution. Recent clinical observations point to alterations in the BC pattern in the Sudan, possibly as a result of lifestyle changes brought on by the enormous migration from rural to urban locations. This study aimed to identify the pattern of bladder cancer in Darfur.

Patients and Methods: A cross sectional, hospital-based study, it was conducted inNyala specialized hospital, during the period from (2020 to 2022), included one hundred and five patients with bladder mass matching the inclusion criteria were studied over the diversity of demographic data , clinical finding, pathological type and possible risk factors .

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    105 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Patterns of Urinary Bladder Cancer in Darfur, Sudan 2020 - 2022
    Actual Study Start Date :
    Nov 1, 2020
    Actual Primary Completion Date :
    Apr 1, 2022
    Actual Study Completion Date :
    Apr 10, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Patterns of Urinary Bladder Cancer in Darfur, Sudan [The research is a cross-sectional, hospital-based study conducted at Nyala Specialized Hospital in Darfur. The study spans a period from 2020 to 2022.]

      This research study investigates the patterns of urinary bladder cancer (BC) in Darfur, Sudan, with a focus on understanding the clinical outcomes, etiology, histology, and demographic distribution of the disease.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • All Sudanese pts who lives in Darfur and presented with urinary bladder mass.

    • Adult above 18 years

    Exclusion Criteria:

    • Patient who does not live in Darfur.

    • Patients refused to participate in the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Nyala specialized hospital Darfur Sudan 00000

    Sponsors and Collaborators

    • National Center for Gastroentestinal and Liver Disease

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Center for Gastroentestinal and Liver Disease
    ClinicalTrials.gov Identifier:
    NCT06156787
    Other Study ID Numbers:
    • ElbagieaBladder
    First Posted:
    Dec 5, 2023
    Last Update Posted:
    Dec 5, 2023
    Last Verified:
    Nov 1, 2023
    Additional relevant MeSH terms:
    Urinary Bladder Neoplasms

    Study Results

    No Results Posted as of Dec 5, 2023